⚠️ Evidence Review / Observational Evidence Dominant
Coffee is among the world’s most widely consumed beverages, making its potential role in cancer prevention a topic of significant interest. This review summarizes recent evidence linking coffee intake with lower risks of several malignancies while highlighting important limitations of the current research.
Key Findings
- The strongest evidence appears to support an inverse association between coffee consumption and hepatocellular carcinoma (HCC) as well as endometrial cancer.
- Observational studies have also reported associations between coffee intake and lower risks of head and neck cancer, colorectal cancer recurrence and mortality, lung cancer, and certain prostate cancer outcomes.
- Protective associations have been observed with both caffeinated and decaffeinated coffee, suggesting caffeine alone is unlikely to explain the findings.
- Proposed mechanisms include modulation of inflammation, oxidative stress, insulin sensitivity, liver fibrosis, carcinogen metabolism, immune signaling, and the gut microbiome.
- Some evidence suggests heavily sweetened coffee may diminish potential metabolic benefits.
Practical Takeaways
- Do not recommend initiating coffee consumption solely for cancer prevention based on current evidence.
- Reassure most patients that moderate coffee consumption appears generally safe and is not associated with increased risk for most cancers.
- Consider individual contraindications, including reflux, insomnia, anxiety, palpitations, or treatment-related symptoms.
- Interpret reported benefits as associations rather than proof of a causal cancer-preventive effect.
PATIENT EDUCATION
OBESITY/WEIGHT MANAGEMENT
EXERCISE/TRAINING
LEGAL MATTERS
GUIDELINES/RECOMMENDATIONS